ER low-positive breast tumors have comparable progesterone receptor (PR) levels12,15, tumor grade10–13,16 and Ki-67 expression11,13,16 to TNBC and are usually classified as basal-like or HER2-enriched11,15,17. This evidence concerns the gene ESR1 and breast neoplasm.